Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Mihaela Zidarn (Golnik, Slovenia), Mihaela Zidarn, Susan Wilson, Peter Howarth. Immunocytochemistry evaluation of FKBP51 in induced sputum cells as a biomarker of glucocorticoid therapy in asthma. Eur Respir J 2015; 46: Suppl. 59, 596

Member's Comments

No comment yet.

Related content which might interest you: Activin-A BAL levels and Immunochemistry for activin A receptors in patients with asthma Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Induced sputum cytology and pulmonary function tests in ex-smoker asthmatic patients controlled with inhaled steroid and long acting beta agonist therapy Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015 Reactive oxygen metabolite levels are surrogate biomarkers for predicting exacerbation of bronchial asthma Source: International Congress 2016 – Systemic biomarkers Year: 2016 TH2 specific biomarker profile determines steroid responsiveness in severe asthma Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Cytological and mRNAs peripheral blood markers of aspirin intolerance in asthmatics Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control Source: International Congress 2014 – Airway biomarkers Year: 2014 Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 TNFAIP3 (A20) expression is elevated in the sputum of severe asthmatics Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Sputum YKL-40 is a potential biomarker of COPD-asthma overlap Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Blockade of TSLP pathway alters asthma biomarkers Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases Year: 2014 Activin –A and follistatin in sputum supernatant and BAL in patients with asthma Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma Source: Annual Congress 2013 –Asthma Year: 2013 Diagnostic implications of sTREM-1 in induced sputum and BAL fluid of patients with asthma and COPD Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Oxidative stress and biomarkers in patients with bronchial asthma Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Various biomarkers of oxidative stress in patients with uncontrolled asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013